SI1639013T1 - Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy - Google Patents

Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy

Info

Publication number
SI1639013T1
SI1639013T1 SI200431971T SI200431971T SI1639013T1 SI 1639013 T1 SI1639013 T1 SI 1639013T1 SI 200431971 T SI200431971 T SI 200431971T SI 200431971 T SI200431971 T SI 200431971T SI 1639013 T1 SI1639013 T1 SI 1639013T1
Authority
SI
Slovenia
Prior art keywords
kir2dl
pan
diagnostic
therapy
receptor antibodies
Prior art date
Application number
SI200431971T
Other languages
Slovenian (sl)
Inventor
Allessandro Moretta
Chiesa Mariella Della
Original Assignee
Innate Pharma
Universita Di Genova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Pharma, Universita Di Genova filed Critical Innate Pharma
Priority claimed from PCT/IB2004/002464 external-priority patent/WO2005003172A2/en
Publication of SI1639013T1 publication Critical patent/SI1639013T1/en

Links

SI200431971T 2003-07-02 2004-07-01 Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy SI1639013T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48389403P 2003-07-02 2003-07-02
US54547104P 2004-02-19 2004-02-19
PCT/IB2004/002464 WO2005003172A2 (en) 2003-07-02 2004-07-01 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
EP04744115A EP1639013B1 (en) 2003-07-02 2004-07-01 Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy

Publications (1)

Publication Number Publication Date
SI1639013T1 true SI1639013T1 (en) 2013-01-31

Family

ID=37031117

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431971T SI1639013T1 (en) 2003-07-02 2004-07-01 Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy

Country Status (4)

Country Link
CN (2) CN1852924A (en)
ES (1) ES2358078T3 (en)
SI (1) SI1639013T1 (en)
ZA (2) ZA200600792B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2109460B1 (en) * 2007-01-11 2016-05-18 Novo Nordisk A/S Anti-kir antibodies, formulations, and uses thereof
CN101804193B (en) * 2009-02-16 2012-09-26 重庆西南医院 CTLA4lg and derivatives thereof used for resisting viruses
WO2010091542A1 (en) * 2009-02-16 2010-08-19 重庆西南医院 Anti-tumor, anti-bacterial and/or anti-viral applications of ctla4ig and derivatives thereof.
US20130267613A1 (en) * 2010-10-06 2013-10-10 St Jude Children's Research Hospital Molecular-determinant based typing of kir alleles and kir-ligands
AR083957A1 (en) * 2010-11-22 2013-04-10 Innate Pharma Sa TREATMENT TO MODULATE NK CELLS AND METHODS TO TREAT HEMATOLOGICAL MALIGNITY
AU2012260601B2 (en) * 2011-05-25 2018-02-01 Innate Pharma, S.A. Anti-KIR antibodies for the treatment of inflammatory disorders
CN104914242B (en) * 2014-09-29 2017-08-11 深圳华大基因科技服务有限公司 For cancer diagnosis and the method and composition for the treatment of

Also Published As

Publication number Publication date
CN1842541A (en) 2006-10-04
CN1842541B (en) 2013-03-27
ZA200600792B (en) 2007-04-25
ZA200600842B (en) 2007-04-25
CN1852924A (en) 2006-10-25
ES2358078T3 (en) 2011-05-05

Similar Documents

Publication Publication Date Title
IL172316A0 (en) Novel compounds and their use in therapy
HK1081448A1 (en) Bispecific anti-erb-b antibodies and their use in tumor therapy
SI2287195T1 (en) Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
IL163563A (en) Anti-amyloid beta antibodies and their use in medicine
IL190332A0 (en) Human antibodies against il13 and therapeutic uses
GB0418542D0 (en) Integrated biosensor and simulation system for diagnosis and therapy
AU2003278807A8 (en) KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
EP2014310B8 (en) KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
IL182652A0 (en) Nitrobenzindoles and their use in cancer therapy
EP1781685A4 (en) Therapeutic and diagnostic agents
EP1572741A4 (en) Therapeutic and diagnostic agents
AU2003227148A8 (en) Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer
GB0303663D0 (en) Assays and medical treatments
GB0308382D0 (en) Therapeutic methods and means
SI1639013T1 (en) Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy
GB0326578D0 (en) Cancer diagnosis and therapy
SG110107A1 (en) Compound and use in treatment
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
GB0318546D0 (en) Quinoxalinones and their use
EP1666046A4 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
AU2003209459A8 (en) Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
ZA200802541B (en) Human antibodies against IL13 and therapeutic uses
GB0424871D0 (en) Antibodies and their use in therapy
GB0505908D0 (en) Antibodies and their use in therapy